© Copyright Nostre Net
Market Insights
Healthcare research and the high demand for food are key areas where next-generation sequencing is being used extensively. Increasing genetic disorders are being diagnosed which has drastically increased the demand for next-generation sequencing. Moreover, the use of this technology in drug discovery is significant and expected to drive growth as the demand for effective drug therapies increases.
Also known as massive parallel sequencing or high throughput sequencing technology, next-gen sequencing has been transformative for the field of genomic research as it allows the sequencing of a complete human genome in a very short amount of time. During the process, the genetic material is extracted, fragmented, and associated with various factors for amplification. As such, this technology is highly effective and advanced thus driving its adoption and growth. The improved speed and reduced costs are expected to drive market growth. Use in clinical applications, agricultural applications, and forensic applications are growing rapidly.
Increasing awareness, employment of various growth strategies and ongoing technical advancements are expected to provide the market with ample opportunity for growth. However, the high initial cost of implementing technologies, and the requirement for storage of large volumes of data as well as a lack of skilled workforce to run the technology are challenges to the growth of the Next Generation Sequencing market.
DNA technology has come a long way, and next generation sequencing is expected to take DNA technology further than ever before. Market Research Future's report on the global next-generation sequencing market divulges key details regarding the growth of the market as well as various vital facts, figures, and prediction of growth of the global market.
Key Players
Oxford Nanopore Technologies, Ltd., BGI, Pacific Biosciences of California, Inc., PerkinElmer, QIAGEN N. V., Eurofins Scientific, Agilent Technologies, Macrogen Inc, Illumina, Inc., and Thermo Fisher Scientific, Inc. are among the notable market players that have been included in MRFR’s competition tracking of the global next generation sequencing market.
Market Segmentation
Analysis of the markets several parts are included in MRFR's segmental analysis which has been performed on the basis of technology, service & product, application, end-user, and region.
The technology used in next-generation sequencing includes whole exome sequencing, CHIP sequencing, whole genome sequencing, methyl sequencing, targeted resequencing, de novo sequencing, and RNA sequencing, next generation sequencing data analysis.
By service & product, the next generation sequencing market has been segmented into consumables, sample preparation, platforms & services for platforms, and sequencing services. The sample preparation segment is further divided into end repair, A-tailing & size selection, quality control, library preparation & target enrichment, and DNA fragmentation. Other sub-segmentations have been mentioned and expounded on in the report.
Applications of next-generation sequencing include genetic screening, drug discovery, diagnostics, agriculture & animal research, and others.
End-users of next-generation sequencing include hospitals & clinics, academic institutes & research centers, pharmaceutical & biotechnology companies, and other end-users.
Regional Analysis
The global next generation sequencing market is segmented into key regions which include the Americas, Asia Pacific, Europe, and the Middle East & Africa. North America in the Americas region is slated to lead the market with the largest share due to the high competition between market players in the region as well as the rising demand for next-gen sequencing in the healthcare sector of developed economies such as the US and Canada. Moreover, the presence of a significant healthcare sector in the region combined with growing investments in healthcare toward the development of therapies for chronic diseases will push growth during the forecast period.
The European region has the second largest market due to the significant R&D activities that take place in the region with regards to various fields including healthcare. The presence of pioneering next-gen sequencing technology market players are expected to make an impact on the market. However, growth here is restrained due to regulations and fragmentation of the market across Europe.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Cerebral palsy is defined as a group of disorders that affect muscle movement and coordination, which in many cases, impairs vision, hearing, sensation and others senses. Cerebral palsy is a congenital disorder of movement, muscle tone or posture and can affect a person’s posture, balance and ability to move, communicate, eat, sleep and learn. According to the Centre for Disease Control 1 to 4 out of every 1,000 children across the globe are affected by cerebral palsy, thereby creating a strong demand for dia gnosis, and treatment for the condition which will drive growth for cerebral palsy market.
Competitive Overview:
Allergen Plc, Cellular Biomedicine Group, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories, Acorda Therapeutics, Inc., Medtronic, Meridigen Biotech Co., Ltd., GW Pharmaceuticals Plc, and Cell Cure Neurosciences Ltd. are some of the key players in the global cerebral palsy market.
Segmentation
The cerebral palsy market has been segmented into type, diagnosis, and treatment.
On the basis of type, cerebral palsy market has been segmented into hypotonic cerebral palsy, spastic cerebral palsy, ataxic cerebral palsy, dyskinetic cerebral palsy, and mixed cerebral palsy.
By diagnosis, CP market segmentation includes imaging tests and others. The imaging tests segment has been further classified into computed tomography, magnetic resonance imaging (MRI), cranial ultrasound, and electroencephalogram.
Based on treatment, cerebral palsy market has been segmented into therapy, medication, surgery, cerebral palsy drugs and others.
Regional Market Summary
Geographically, the Americas region is anticipated to dominate the global cerebral palsy market owing to a well-developed healthcare sector, rising prevalence of cerebral palsy and growing healthcare expenditure. Additionally, favorable reimbursement scenario in this region and a relatively large number of research and development (R&D) activities contributes to the growth of the market.
Europe is expected to hold the second largest position in the global cerebral palsy market. The market growth in this region is attributed to the growing prevalence of cerebral palsy, availability of funds for research, and increasing healthcare expenditure. According to the data stated by the National Institute for Health and Care Excellence (NICE) in 2017, in the UK, it is estimated that 1 in 400 babies are born with cerebral palsy. It also stated that approximately 1,800 children diagnosed with CP each year.
The cerebral palsy market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, rising prevalence of cerebral palsy and increasing government funding for the healthcare sector.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Overview:
The global nutraceutical excipients market is growing pervasively. The market growth is mainly driven by the burgeoning nutraceutical sector. In 2017, the market had reached USD 3104.96 Mn and is expected to value at USD 4818.70 Mn. by 2023. Excipients are inactive components added to nutraceuticals during its production to help stabilize the ingredients. Nutraceutical excipients perceive augmenting demand, which in turn, substantiates its market size globally.
Hike in investment related to healthcare, transforming lifestyle triggering various diseases, and others are major factors that can significantly inspire the growth rate of the market. The growing awareness among people regarding health benefits, an increasing number of products entering the pipeline, and others can inspire the growth of the market. On the other hand, stringent regulations can hold back the growth rate in the coming years. But the market can bank on the developing technologies for better growth assistance.
Competitive Landscape:
A lot of companies are trying to make the market for the global nutraceutical excipients prosper with high growth opportunities. These segments are known for extensive participation in taking the market ahead. MRFR recorded their recent steps to gauge in which direction the market is moving and find better growth possibilities there. These companies are Ingredion, Cargill Corporation, Kerry, Sensient Technology Corporation, Associated British Foods plc, JRS PHARMA, Roquette Freres SA, DowDupont, Innophos, Inc., and Hilmar Ingredients.
Segmentation:
The global market for nutraceutical excipients is set to find a segmentation in the report that would be based on form, function, type, and application. These segments have a better acceptance of various factors that can be taken into consideration to understand how the market can chart the future path.
By function, the market for nutraceutical excipients can be segmented into fillers, diluents & bulking agents, disintegrants, binders, lubricants, sweeteners, coating agents, and colors & flavors. The fillers, diluents & bulking agents have a chance to expand at 8.34% CAGR during the forecast period.
By form, the market for nutraceutical excipients can be segmented into liquid and dry. The former has a better market share. It has a coverage of almost 55% of the global market. It had a market valuation of USD 1 Bn in 2017. The dry segment can score a 7.34% CAGR during the review period.
By application, the market for nutraceutical excipients can be segmented into omega-3 fatty acids, proteins & amino acids, probiotics & prebiotics, and vitamins & minerals. The probiotics & prebiotics segment had the market command in 2017 when it had coverage of 47.5% market share. Its CAGR would be impressive. However, the vitamins & minerals segment has the chance for growth with a CAGR of 7.92% during the forecast period.
By type, the market report that includes nutraceutical excipients can be segmented into artificial and natural/organic. The artificial segment had better market dominance in 2018. But growing consumer awareness can inspire a better intake of the natural/organic nutraceuticals products.
Regional Analysis:
The Americas have a high chance of contributing the maximum revenues in terms of fetching from the profit. The regional market has North and South America. North America includes the US and Canada where various global nutraceutical excipients market players are gaining hike from increasing chronic diseases, high health-related investment, better awareness, assistance from various policies, and others are expected to create better provision for the global market. Various changes in the lifestyle have influenced a hike in various diseases like diabetes, respiratory issues, and others. The market in Europe is expected to establish itself as the second-best market. Its resemblance to North America can inspire better market growth. Health cost expenditure in the region is quite high owing to which the market can witness better growth. Its intake as a preventive measure is quite high in the region.
The market in Asia-Pacific has potential as the region has several developed and fast-developing countries. For instance, markets like Australia, Japan, India, China, and South Korea can inspire the global market to register the fastest CAGR in the coming years. The market would benefit from a large number of consumers as well.
Access full report @ https://www.marketresearchfuture.com/reports/nutraceutical-excipients-market-6097
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America